Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 2
2023 2
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Cancer Immunotherapy-An Overview.
Kulkarni P, Do D, Shrestha S, Leach B, Salgia R. Kulkarni P, et al. Among authors: shrestha s. Cancer Treat Res. 2025;129:1-16. doi: 10.1007/978-3-031-97242-3_1. Cancer Treat Res. 2025. PMID: 40847226 Review.
Phenotypic Plasticity and Cancer: A System Biology Perspective.
Subbalakshmi AR, Ramisetty S, Mohanty A, Pareek S, Do D, Shrestha S, Khan A, Talwar N, Tan T, Vishnubhotla P, Singhal SS, Salgia R, Kulkarni P. Subbalakshmi AR, et al. Among authors: shrestha s. J Clin Med. 2024 Jul 23;13(15):4302. doi: 10.3390/jcm13154302. J Clin Med. 2024. PMID: 39124569 Free PMC article. Review.
Current paradigm of EGFRins20 in non-small cell lung cancer: A long way forward.
Miyamura BV, Mambetsariev I, Fricke J, Arias-Romero J, Cadman K, Shrestha S, Pisick E, Nguyen D, Malhotra J, Reyes A, Salgia R. Miyamura BV, et al. Among authors: shrestha s. Med. 2025 Sep 12;6(9):100803. doi: 10.1016/j.medj.2025.100803. Epub 2025 Aug 8. Med. 2025. PMID: 40782807 Free article. Review.
Addressing Drug Resistance in Cancer: A Team Medicine Approach.
Kulkarni P, Mohanty A, Bhattacharya S, Singhal S, Guo L, Ramisetty S, Mirzapoiazova T, Mambetsariev B, Mittan S, Malhotra J, Gupta N, Kim P, Babikian R, Rajurkar S, Subbiah S, Tan T, Nguyen D, Merla A, Kollimuttathuillam SV, Phillips T, Baik P, Tan B, Vashi P, Shrestha S, Leach B, Garg R, Rich PL, Stewart FM, Pisick E, Salgia R. Kulkarni P, et al. Among authors: shrestha s. J Clin Med. 2022 Sep 27;11(19):5701. doi: 10.3390/jcm11195701. J Clin Med. 2022. PMID: 36233569 Free PMC article.
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies.
Ramisetty S, Subbalakshmi AR, Pareek S, Mirzapoiazova T, Do D, Prabhakar D, Pisick E, Shrestha S, Achuthan S, Bhattacharya S, Malhotra J, Mohanty A, Singhal SS, Salgia R, Kulkarni P. Ramisetty S, et al. Among authors: shrestha s. J Clin Med. 2024 Jun 5;13(11):3337. doi: 10.3390/jcm13113337. J Clin Med. 2024. PMID: 38893049 Free PMC article.
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
Alva AS, Mangat PK, Garrett-Mayer E, Halabi S, Hansra D, Calfa CJ, Khalil MF, Ahn ER, Cannon TL, Crilley P, Fisher JG, Haslem DS, Shrestha S, Antonelli KR, Butler NL, Warren SL, Rygiel AL, Ranasinghe S, Bruinooge SS, Schilsky RL. Alva AS, et al. Among authors: shrestha s. J Clin Oncol. 2021 Aug 1;39(22):2443-2451. doi: 10.1200/JCO.20.02923. Epub 2021 Apr 12. J Clin Oncol. 2021. PMID: 33844595 Clinical Trial.